Study of Antibiotic Sensitivity Pattern In Urinary Tract Infection At A Tertiary Hospital
Antibiotic Sensitivity Pattern In Urinary Tract Infection
DOI:
https://doi.org/10.70284/njirm.v2i3.1919Keywords:
Antibiotic Sensitivity, Uropathogens, Urinary Tract InfectionAbstract
This study was conducted in a tertiary hospital at Bareilly, Uttar Pradesh between Aug 2009 and July 2010 to check the changing pattern of antibiotic sensitivity among uropathogens causing urinary tract infections (UTI). A total of 170 urine culture sensitivity reports were analyzed. The predominant growth of single bacteria was seen in 143 (84.12%) samples. The most common organisms isolated were Escherichia coli, klebsiella, pseudomonas, and Staphylococcus aureus. (These represented 64.33%, 92; 20.3%, 29; 9.1%, 13 and 6.30%, 9 of isolates respectively). More than 80% of the isolates were sensitive to amikacin and nitrofurantoin, while more than 70% were sensitive to norfloxacin, ciprofloxacin and levofloxacin. Very high rate of resistance was seen against cotrimoxazole (81.82%), amoxicillin (77.42%) and amoxi-clav (64.34%). E. coli showed high sensitivity to Amikacin 98.91% (91), Nitrofurantoin 93.48% (86). 75% of E. coli isolates were sensitive to minocycline, showing a good utility of this drug for the treatment of outdoor patients with urinary tract infections.
References
2. Nicole W, Jon DM. Deciphering Dysuria. Emerg Med. 2008; 40(9): 29.
3. Jenson BH, Baltimore RS. Infectious Diseases. Nelson Essentials of Pediatrics 5th edition. Elsevier Inc. 2006; p.522.
4. Stamm WE, Schaeffer AJ. The State of the Art in the management of Urinary Tract Infections. Am J Med 2002; (suppl 1 A): 113.
5. Blondeau JM. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option. Drugs. 2004; 64(6): 611-28.
6. Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis. 2000; 19:112-7.
7. Ashkenazi S, EvenTov S, Samra Z, et al. Uropathogens of various childhood populations and their antibiotic susceptibility. Pediatr Infect Dis J. 1991; 10: 742–6.
8. New HC. Urinary tract infections. Am J Med. 1996; 100 (Suppl.4A): S63-70.
9. Jones RN. Impact of changing pathogens and antimicrobial susceptibility pattern in treatment of serious infections in hospitalized patients. Am J Med. 1996; 100 (Suppl.6A): S3-12.
10. Yilmaz K, Nilay C, Aysegül G, et al. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years. International J Antimicrbial Agents. 2005; 26 (1): 75-77.
11. Carson C, Naber KG. Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections. Drugs. 2004; 64(12):1359-73.
12. Shigemura K, Tanaka K, Adachi M, et al. Chronological change of antibiotic use and antibiotic resistance in Escherichia coli causing urinary tract infections. J Infect Chemother. 2011; Apr 14. [Epub ahead of print].
13. Delzell JE Jr, Leferre ML. Urinary tract infections during pregnancy. Am Fam Physician. 2000; 61(3): 713-721.
14. Biswas D, Gupta P, Prasad R, et al. Choice of antibiotic for empirical therapy of acute cystitis in a setting of high antimicrobial resistance. Indian J Med Sci. 2006; 60: 53-58.
15. James AK, Laurie J, Clyde T, et al. Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States. Antimicrob Agents Chemother. 2002; 46(8): 2540-2545.
16. Bours PH, Polak R, Hoepelman AI, et al. Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines. Int J Infect Dis. 2010; 14(9): 770-4.
